US WorldMeds Receives $15 Million Grant to Launch New Study
US WorldMeds Receives Million Grant to Launch New Study
Lofexidine is approved in the United Kingdom as BritLofex® and has been used in successful detoxification of more than 200,000 opiate addicts. US WorldMeds acquired a license for Lofexidine from Britannia Pharmaceuticals in … Lofexidine trial sites …
Read more on Business Wire (press release)